Recorded device evidence

Invisalign System with Mandibular Advancement Featuring Occlusal Blocks (K232233): indications, design and recorded evidence

The acquired K232233 file contains product-specific indications and users, recorded comparison and differences, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 77 selected decisions under primary code NXC. 77 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 61.0, median 103.0, upper quartile 225.0. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K232233 ↗ · this pageInvisalign System with Mandibular Advancement Featuring Occlusal Blocks2023-07-27 → 2023-09-2661Traditional
K260527 ↗FACE4D Aligner2026-02-17 → 2026-07-02135Traditional
K260788 ↗Smylio Aligners2026-03-10 → 2026-05-0859Traditional
K260722 ↗SureSmile Aligner (ASSY500020)2026-03-05 → 2026-04-1541Traditional
K253282 ↗ZSmile System2025-09-29 → 2026-02-03127Special

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K232233 · PDF page 7 ↗ Source 2

Read this statement in the original PDF; no complete statement fits the short excerpt.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Recorded comparison and differences

K232233 · PDF page 9 ↗ Source 3

Principle of                        Aligners: Sequential aligners                                  Aligners: Sequential                               Aligners: Sequential                             Same as predicate
Operation                           apply continuous gentle force to                               aligners apply continuous                          aligners apply                                   device
                                    the teeth and/or position                                      gentle force to the teeth                          continuous gentle force
                                    mandible forward.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Performance evidence actually described

K232233 · PDF page 10 ↗ Source 4

Durability                            The Invisalign System,                                           Same design as                                       The Invisalign                                     Same as
(Normal U se)                         MAOB sustained cyclic                                            Referenc e Device                                    System w ith MA                                    predicate device
                                      loading w ithout br eakages.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK232233 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryInvisalign System with Mandibular Advancement Featuring Occlusal Blocks [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantAlign Technology, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeNXC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2023-09-26 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2023-07-27 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[24164] · record 5ce04aa56eff19984d10c9b8d132b3768fbca44b12f0b9f107ee3032dcfdcb75
  • [5] Complete results array / fda-decision-context:K232233 · record whole dataset partition

FDA 510(k) summary — K232233 ↗

Wed, 27 Sep 2023 15:25:08 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot aa3a0c609db8b081130096f1dee8d017e8665bf696f38a5fe3281fecc0d77333

  • [2] PDF page 7 · record d9fab497ffc0379bf72d670a7c5a419da25e2422eccc210d68e4fac6686e55c1
  • [3] PDF page 9 · record 9911f2ab11b5b7bda553256f464047c47f654b9a1c3aba18b2a484b9ce502e2b
  • [4] PDF page 10 · record f701f5d15704193d224b0c1ed8139733f3591ea357157059ed2b5120755a40dd

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services